Physician Quick Search
By Name:
By Specialty:
When you need to get the name of one of the nation’s top doctors as close to home as St. Louis, just call 314-TOP-DOCS (314-867-3627) or toll free 1-866-867-3627. This is the physician referral and health information line from Barnes-Jewish Hospital.
Your Healthy Update

Like us on Facebook
Text Size: S M L

Internal Medicine / Gastroenterology

Jeffrey S. Crippin, MD

Current Position
Marilyn Bornefeld Endowed Chair in GI Research and Treatment
Professor, Medicine
Division of Gastroenterology
Medical Director, Liver Transplantation
Co-Director, GI Center, Clinical Operations

Specialty Areas
Liver Transplantation
Liver Diseases

Patients Seen At
Center for Advanced Medicine
GI Center
4921 Parkview Place, C, 8
St. Louis, MO  63110
Fax:   314-454-5108
View Floor Map  View Campus Map   View Driving Directions

Medical Building Two
Barnes-Jewish West County Hospital
10 Barnes West Drive, Suite 200
Creve Coeur, MO  63141
Fax:   314-747-1277
View Campus Map   View Driving Directions

Mailing Address
Washington University School of Medicine, Division of Gastroenterology
660 South Euclid Avenue, Campus Box 8124
St. Louis, MO  63110

Areas of Clinical Interest
Liver transplant, acute/chronic liver disease, hepatitis, cirrhosis, liver transplantation

Board Certification
Gastroenterology -- Certified
Internal Medicine -- Certified
Transplant Hepatology Certificate of Added Qualification

Medical Education
B.S.: University of Notre Dame, Notre Dame, Indiana, 1980
Medical Degree: University of Kansas, Kansas City, Kansas, 1984
Residency: Kansas University Medical Center, Kansas City, Kansas, 1987
Chief Resident: Internal Medicine, Kansas University Medical Center, Kansas, 1988
Fellowship: Gastroenterology, Mayo Clinic, Rochester, Minnesota, 1991
Hospital Affiliations
Barnes-Jewish Hospital

Honors and Awards
Listed in Best Doctors in America, 2003-2013 (Best Doctors, Inc.)
Listed in America's Top Doctors, 2005-2012 (Castle Connolly Medical Ltd.)
President, American Soicety of Transplantation, 2006-2008

Disclosure of Financial Interests with Industry
Washington University and its physicians are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians work collaboratively with pharmaceutical or medical device companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our faculty physicians are paid by these commercial companies to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this web site, physicians earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

Dr. Jeffrey S. Crippin reported the following earned financial interests during calendar year 2014. Move your mouse over a header for more info.
Royalties: When a faculty member invents or conceives a new or improved process or product, the company that manufactures the product will make royalty payments to the faculty member. Royalty payments usually are a small percentage of the company’s revenue related to that product.
Consulting &
Advisory Boards
Consulting and Advisory Boards: Faculty may be paid to provide expertise to a company by being their consultant, or by serving on an advisory board.
Speaker Fees
Speaker Fees: Companies may pay faculty to speak to professional audiences about their products.
Genentech   $25,001-$50,000 
Gilead   $50,001-$100,000 
To learn more about Washington University's policies on collaborations with industry, click here.

Editorial Responsibilities

Editorial Board
Liver Transplantation

Selected or Recent Journal Articles
Rude M, Watson R, Crippin J. Recurrent hepatic epithelioid hemangioendothelioma after orthotopic liver transplantation. Hepatology. 2013 Oct 12.

Ramachandran S, Ilias Basha H, Sarma NJ, Lin Y, Crippin JS, Chapman WC, Mohanakumar T. Hepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosis. PLoS One. 2013 Aug 12;8(8):e70744.

Blinder MA, Geng B, Lisker-Melman M, Crippin JS, Korenblat K, Chapman W, Shenoy S, Field JJ. Successful orthotopic liver transplantation in an adult patient with sickle cell disease and review of the literature. Hematol Rep. 2013 May 2;5(1):1-4.

Subramanian V, Bharat A, Vachharajani N, Crippin J, Shenoy S, Mohanakumar T, Chapman WC. Perioperative blood transfusion affects hepatitis C virus (HCV)-specific immune responses and outcome following liver transplantation in HCV-infected patients. HPB (Oxford). 2013 Jul 22.

Ma C, Crippin JS, Chapman WC, Korenblat K, Vachharajani N, Gunter KL, Brunt EM. Parenchymal alterations in cirrhotic livers in patients with hepatopulmonary syndrome or portopulmonary hypertension. Liver Transpl. 2013 Jul;19(7):741-50.

Trudeau RE, Bowman LJ, Wills AR, Crippin JS, Chapman WC, Anderson C. Once weekly fluconazole for antifungal prophylaxis post-liver transplantation. HPB (Oxford). 2013 Jul;15(7):541-7.

Sarma NJ, Tiriveedhi V, Subramanian V, Shenoy S, Crippin JS, Chapman WC, Mohanakumar T. Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway. PLoS One. 2012;7(11):e50826.

Sarma NJ, Tiriveedhi V, Ramachandran S, Crippin J, Chapman W, Mohanakumar T. Modulation of immune responses following solid organ transplantation by microRNA. Exp Mol Pathol. 2012 Dec;93(3):378-85

Gordon FD, Kwo P, Ghalib R, Crippin J, Vargas HE, Brown KA, Schiano T, Chaudhri E, Pedicone LD, Brown RS Jr. Peginterferon-α-2b and Ribavirin for Hepatitis C Recurrence Postorthotopic Liver Transplantation. J Clin Gastroenterol. 2012 Sep.

Criswell SR, Perlmutter JS, Crippin JS, Videen TO, Moerlein SM, Flores HP, Birke AM, Racette BA. Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels. Arch Neurol. 2012 Mar.

Seetharam AB, Borg BB, Subramanian V, Chapman WC, Crippin JS, Mohanakumar T. Temporal association between increased virus-specific Th17 response and spontaneous recovery from recurrent hepatitis C in a liver transplant recipient. Transplantation. 2011 Dec 27.

Subramanian V, Seetharam AB, Vachharajani N, Tiriveedhi V, Angaswamy N, Ramachandran S, Crippin JS, Shenoy S, Chapman WC, Mohanakumar T, Anderson CD. Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation. Transplantation. 2011 Dec 15.

Basha HI, Subramanian V, Seetharam A, Nath DS, Ramachandran S, Anderson CD, Shenoy S, Chapman WC, Crippin JS, Mohanakumar T. Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis. Am J Transplant. 2011 Apr.

Borg BB, Seetharam A, Subramanian V, Basha HI, Lisker-Melman M, Korenblat K, Anderson CD, Shenoy S, Chapman WC, Crippin JS, Mohanakumar T. Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis. Liver Transpl. 2011 Jul.

Rowley AA, Hong BA, Chapman W, Crippin JS. The psychiatric diagnosis of alcohol abuse and the medical diagnosis of alcoholic related liver disease: effects on liver transplant survival. J Clin Psychol Med Settings. 2010 Sep.

For more articles and abstracts, take this off-site link to the National Library of Medicine Pub Med page for Dr. Jeffrey Crippin.

Washington University Physicians are the medical staff of  Barnes-Jewish Hospital and Children's Hospital - St. Louis Employment   About Us   Top Stories   For Your Protection      Site Map
Copyright 2015 Washington University School of Medicine
Copyright 2015 Washington University School of Medicine